Results 141 to 150 of about 19,346 (234)

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, Volume 158, Issue 9, Page 2298-2308, 1 May 2026.
What's new? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source

Enamel renal syndrome due to FAM20A mutations: challenging kidney management in view of nephrocalcinosis, hypophosphatemia and hypocalciuria. [PDF]

Orphanet J Rare Dis
Eid MT, de Mul A, Muresan-Vintila L, Derain Dubourg L, Bertholet-Thomas A, Molin A, Thivichon-Prince B, Bacchetta J.   +7 more
europepmc   +1 more source

Professionals and the Ethics of Workplace Surveillance

Journal of Social Philosophy, EarlyView.
Steve Clarke, William Tuckwell, Morgan Luck   +2 more
wiley   +1 more source

Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain

Clinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 1088-1094, April 2026.
Pregabalin and duloxetine are widely prescribed non‐opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety.
Sachalee Campbell, Puran Nepal, Laura Daniel, Otis Wilson, Alyson L. Dickson, Jennifer Maizel, Katherine T. Murray, William D. Dupont, Adriana Hung, Wayne A. Ray, C. Michael Stein, Cecilia P. Chung   +11 more
wiley   +1 more source

Os hospices e os programas de voluntariado para o câncer Hospices and volunteer cancer programs

História, Ciências, Saúde: Manguinhos, 2010
Claudia Jurberg, Jaime L. Benchimol Luiz Antonio Teixeira, Ruth B. Martins   +2 more
doaj   +1 more source

Multibipolar radiofrequency <i>vs</i> single needle microwave ablation for the treatment of newly diagnosed hepatocellular carcinoma. [PDF]

World J Gastroenterol
Bahloul C, Rode A, Pradat P, Milot L, Dumortier J, Merle P, Mabrut JY, Boussel L, Della Corte A.   +8 more
europepmc   +1 more source

Short‐Term Efficacy and Long‐Term Limitations of Self‐Expandable Metallic Stent Placement for Colorectal Obstruction due to Extracolonic Malignancies

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Although previous studies have investigated colonic stenting for obstruction due to extracolonic malignancies (ECMs), long‐term data—especially concerning quality of life and chemotherapy resumption—remain insufficient. Methods Clinical data of 25 patients with ECM‐induced colorectal obstruction were retrospectively analyzed.
Masashi Yamamoto, Naoto Osugi, Dai Nakamatsu, Kengo Matsumoto, Koji Fukui, Tsutomu Nishida   +5 more
wiley   +1 more source

Demographic and clinical characteristics, practices, and outcomes of continuous palliative sedation: A multi-setting, province-wide retrospective cohort study. [PDF]

Palliat Med
Gagnon B, Downar J, Nguyen O, Marcoux I, Guay D, Marquis MA, Tshibangu RM, Boivin J, Labeau-Caouette M, Savin A, Parsons HA.   +10 more
europepmc   +1 more source

Dental Rehabilitation After Bone Mandibular Reconstruction for Head and Neck Cancer: A GETTEC Multicenter Study

Head &Neck, Volume 48, Issue 4, Page 950-959, April 2026.
ABSTRACT Background The microvascular bone free flap (MBFF) is the preferred reconstruction after mandibular resection as it facilitates secondary dental rehabilitation. Methods In this multicenter study, patients were included if treated between January 2017 and January 2022 for head and neck cancer with MBFF reconstruction.
Lise‐Marie Roussel, Roxane Elaldi, Marine Anquetil, Emilie Lévêque, Emmanuel Babin, Alexandre Bozec, Audrey Lasne Cardon, Alexandre Boulay, Maud Le Guyader, Sébastien Thureau, Esteban Brenet, Florian Clatot   +11 more
wiley   +1 more source

Real‐World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid Leukemia

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Venetoclax plus azacitidine (V+A) is standard for older, intensive‐ineligible patients with acute myeloid leukemia (AML). Its expanding use in younger, curative‐eligible adults lacks comparative evidence against conventional 7+3 induction, raising uncertainty about potential survival compromise.
Nehemias Guevara Rodriguez, Noemy Coreas Mercado, Syeda Ashna Fatima Kamal, Sandeep Beesabathina, Dawson Foster, Nabeel Rajeh, Ranju Kunwor   +6 more
wiley   +1 more source